Varicella Zoster Virus Latency in Human Ganglia

水痘带状疱疹病毒在人类神经节中的潜伏期

基本信息

  • 批准号:
    6746034
  • 负责人:
  • 金额:
    $ 33.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-12-01 至 2008-11-30
  • 项目状态:
    已结题

项目摘要

Varicella zoster virus (VZV) is an ubiquitous human pathogen. Primary infection causes childhood chickenpox, leading to latency in cranial nerve, dorsal root and autonomic ganglia. VZV reactivation, frequent in the elderly and immunocompromised population, results in significant neurological disease. Zoster and postherpetic neuralgia predominate, but many humans develop myelitis, segmental motor weakness, cranial nerve palsies, and a severe, often fatal vasculopathy in the brain. We have also shown that VZV reactivation can produce chronic intense pain in the absence of rash. Although the mechanism controlling VZV latency is not understood, it is likely to depend upon virus gene transcription, thus providing the rationale for our hypothesis that VZV gene expression in human ganglia during latency functions to maintain latent infection. Identification of the VZV genes expressed during latency is critical to understanding latent infection. Until the advent of high throughput array-based technology, such analyses were not feasible, and <20% of the VZV genome has been analyzed for latent virus transcripts. Further, merely identifying the latently transcribed VZV genes is insufficient. Since control of VZV latency is likely to involve virus proteins, characterization of latently expressed viral proteins is also critical to understanding virus gene regulation. Thus, our long-term goal is the detailed characterization, including functional analysis, of VZV genes expressed in latently infected human ganglia. Our specific aims will: (1) identify latently transcribed VZV genes by transcriptional array analysis, confirm the authenticity of the transcripts by sequencing, and determine the abundance of the virus transcripts by fluorescence-based quantitative (real-time) RT-PCR; (2) construct high affinity epitope-tagged recombinant antibodies to colocalize latently expressed VZV proteins by in situ immunohistochemistry in sections of human ganglia; and (3) initiate protein function analysis using 2-hybrid systems to identify and map protein-protein interactions. We will begin with VZV IE63, the most prevalent and abundant virus transcript detected to date during latency. An in-depth understanding of VZV gene expression and function in latently infected human ganglia will lead to testable models of latent virus gene regulation (in the developing simian varicella virus model) and to therapies designed to reduce morbidity and mortality associated with reactivation of this highly neurotropic human pathogen.
水痘带状疱疹病毒(VZV)是一种普遍存在的人类病原体。原发性感染引起儿童水痘,导致脑神经、背根和自主神经节潜伏。VZV再激活常见于老年人和免疫功能低下人群,可导致严重的神经系统疾病。带状疱疹和带状疱疹后神经痛占主导地位,但许多人发展脊髓炎,节段性运动性无力,脑神经麻痹,和严重的,经常

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RANDALL J. COHRS其他文献

RANDALL J. COHRS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RANDALL J. COHRS', 18)}}的其他基金

Prevention of VZV Reactivation
预防 VZV 重新激活
  • 批准号:
    8476910
  • 财政年份:
    2013
  • 资助金额:
    $ 33.12万
  • 项目类别:
Prevention of VZV Reactivation
预防 VZV 重新激活
  • 批准号:
    8794483
  • 财政年份:
    2013
  • 资助金额:
    $ 33.12万
  • 项目类别:
Prevention of VZV Reactivation
预防 VZV 重新激活
  • 批准号:
    8617880
  • 财政年份:
    2013
  • 资助金额:
    $ 33.12万
  • 项目类别:
Prevention of VZV Reactivation
预防 VZV 重新激活
  • 批准号:
    9208821
  • 财政年份:
    2013
  • 资助金额:
    $ 33.12万
  • 项目类别:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
研究 VZV 诱导的血管外膜成纤维细胞表观遗传修饰导致持续炎症和 VZV 血管病变
  • 批准号:
    10343676
  • 财政年份:
    2009
  • 资助金额:
    $ 33.12万
  • 项目类别:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
研究 VZV 诱导的血管外膜成纤维细胞表观遗传修饰导致持续炎症和 VZV 血管病变
  • 批准号:
    10542746
  • 财政年份:
    2009
  • 资助金额:
    $ 33.12万
  • 项目类别:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
研究 VZV 诱导的血管外膜成纤维细胞表观遗传修饰导致持续炎症和 VZV 血管病变
  • 批准号:
    9491548
  • 财政年份:
    2009
  • 资助金额:
    $ 33.12万
  • 项目类别:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
研究 VZV 诱导的血管外膜成纤维细胞表观遗传修饰导致持续炎症和 VZV 血管病变
  • 批准号:
    10097966
  • 财政年份:
    2009
  • 资助金额:
    $ 33.12万
  • 项目类别:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
人类神经节潜伏期转录的 VZV 基因的相互作用
  • 批准号:
    6565246
  • 财政年份:
    2001
  • 资助金额:
    $ 33.12万
  • 项目类别:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
人类神经节潜伏期转录的 VZV 基因的相互作用
  • 批准号:
    6410649
  • 财政年份:
    2000
  • 资助金额:
    $ 33.12万
  • 项目类别:

相似海外基金

Retinal Ganglion Cell Signaling Regulated By Intrinsic Reactive Oxygen Species
视网膜神经节细胞信号传导受内在活性氧的调节
  • 批准号:
    10588039
  • 财政年份:
    2023
  • 资助金额:
    $ 33.12万
  • 项目类别:
Medications for opioid use disorder differentially modulate intrinsically photosensitive retinal ganglion cell function, sleep, and circadian rhythms: implications for treatment
治疗阿片类药物使用障碍的药物差异调节本质光敏性视网膜神经节细胞功能、睡眠和昼夜节律:对治疗的影响
  • 批准号:
    10783274
  • 财政年份:
    2023
  • 资助金额:
    $ 33.12万
  • 项目类别:
Myopia and Glaucoma, Linked via Mechanotransduction Mechanisms Affecting the Ganglion Cell Complex
近视和青光眼通过影响神经节细胞复合体的机械传导机制联系起来
  • 批准号:
    10656793
  • 财政年份:
    2023
  • 资助金额:
    $ 33.12万
  • 项目类别:
Diverse visual processing properties of novel ganglion cell and amacrine cell types in the human retina
人类视网膜中新型神经节细胞和无长突细胞类型的多样化视觉处理特性
  • 批准号:
    10585887
  • 财政年份:
    2023
  • 资助金额:
    $ 33.12万
  • 项目类别:
Nanoparticle-Based Tracking of Retinal Ganglion Cell Transplant
基于纳米颗粒的视网膜神经节细胞移植追踪
  • 批准号:
    10663516
  • 财政年份:
    2023
  • 资助金额:
    $ 33.12万
  • 项目类别:
Autophagy and Retinal Ganglion Cell Death in Glaucoma
青光眼中的自噬和视网膜神经节细胞死亡
  • 批准号:
    10390035
  • 财政年份:
    2022
  • 资助金额:
    $ 33.12万
  • 项目类别:
Regulating cell-cell interactions to improve donor retinal ganglion cell integration
调节细胞间相互作用以改善供体视网膜神经节细胞整合
  • 批准号:
    10389799
  • 财政年份:
    2022
  • 资助金额:
    $ 33.12万
  • 项目类别:
Role of OPA1 in Retinal Ganglion Cell Differentiation and the Pathogenesis of Dominant Optic Atrophy
OPA1在视网膜神经节细胞分化和显性视神经萎缩发病机制中的作用
  • 批准号:
    10705002
  • 财政年份:
    2022
  • 资助金额:
    $ 33.12万
  • 项目类别:
Gene Expression Regulatory Pathways and Retinal Ganglion Cell Neuroprotection
基因表达调控途径与视网膜神经节细胞神经保护
  • 批准号:
    10611728
  • 财政年份:
    2022
  • 资助金额:
    $ 33.12万
  • 项目类别:
Regulating cell-cell interactions to improve donor retinal ganglion cell integration
调节细胞间相互作用以改善供体视网膜神经节细胞整合
  • 批准号:
    10559535
  • 财政年份:
    2022
  • 资助金额:
    $ 33.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了